The peripheral blood of Aβ binding RBC as a biomarker for diagnosis of Alzheimer's disease

Age and Ageing

Volumn 44, Issue 3, 2015, Pages 458-464

  Lan, Jie ^a   Liu, Jinping ^a   Zhao, Zhuo ^b   Xue, Rong ^a   Zhang, Nan ^a   Zhang, Peilan ^c   Zhao, Peng ^a   Zheng, Fang ^a   Sun, Xuguo ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b Internal Medicine   (China)

^c Huanhu Hospital of Tianjin   (China)

Author keywords

Alzheimer's disease; A fibrils; Older people; Red blood cells; Thioflavin T

Indexed keywords

AMYLOID BETA PROTEIN; THIOFLAVINE; BIOLOGICAL MARKER;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; ERYTHROCYTE; ERYTHROCYTE STRUCTURE; HUMAN; IMAGE PROCESSING; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; NEUROPSYCHOLOGICAL TEST;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BIOMARKERS; CASE-CONTROL STUDIES; ERYTHROCYTES; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; NEUROPSYCHOLOGICAL TESTS;

EID: 84929154954     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afv009     Document Type: Article

References (30)

1. Honjo K, Black SE, Verhoeff NPLG. Alzheimer's disease, cerebrovascular disease, and the β-amyloid cascade. Can J Neurol Sci 2012; 39: 712-28.
2. de la Torre JC. Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol 2004; 3: 184-90.
3. Chimon S, Shaibat MA, Jones CR et al. Evidence of fibril-like β-sheet structures in a neurotoxic amyloid intermediate of Alzheimer's β-amyloid. Nat Struct Mol Biol 2007; 14: 1157-64.
4. Cameron B, Landreth GE. Inflammation, microglia and Alzheimer's disease. Neurobiol Dis 2010; 37: 503.
5. Sultana R, Butterfield DA. Oxidatively modified, mitochondriarelevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment. J Bioenerg Biomembr 2009; 41: 441-6.
6. Jayakumar R, Kusiak JW, Chrest FJ et al. Red cell perturbations by amyloid β-protein. Biochim Biophys Acta 2003; 1622: 20-8.
7. Ravi LB, Poosala S, Ahn D et al. Red cell interactions with amyloid-β 1-40 fibrils in a murine model. Neurobiol Dis 2005; 19: 28-37.
8. Mohanty JG, Eckley DM, Williamson JD et al. Do red blood cell-β-amyloid interactions alter oxygen delivery in Alzheimer's disease? In: Kang KA, Bruley DF, eds. Oxygen Transport to Tissue XXIX. USA: Springer, 2008; 29-35.
9. Nakagawa K, Kiko T, Miyazawa T et al. Amyloid β-induced erythrocytic damage and its attenuation by carotenoids. FEBS Lett 2011; 585: 1249-54.
10. Kiko T, Nakagawa K, Satoh A et al. Amyloid β Levels in human red blood cells. PloS One 2012; 7: e49620.
11. Mohanty JG, Shukla HD, Williamson JD et al. Alterations in the red blood cell membrane proteome in Alzheimer's subjects reflect disease-related changes and provide insight into altered cell morphology. Proteome Sci 2010; 8: 11.
12. Oma S, Mawatari S, Saito K et al. Changes in phospholipid composition of erythrocyte membrane in Alzheimer's disease. Dement Geriatr Cogn Dis Extra 2012; 2: 298-303.
13. Bosman G, Bartholomeus IGP, De Man AJM et al. Erythrocyte membrane characteristics indicate abnormal cellular aging in patients with Alzheimer's disease. Neurobiol Aging 1991; 12: 13-8.
14. Lambert MP, Velasco PT, Chang L et al. Monoclonal antibodies that target pathological assemblies of A β. J Neurochem 2007; 100: 23-35.
15. Kayed R, Head E, Sarsoza F et al. Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Mol Neurodegener 2007; 2: 18.
16. Barghorn S, Nimmrich V, Striebinger A et al. Globular amyloid β-peptide 1-42 oligomer-a homogenous and stable neuropathological protein in Alzheimer's disease. J Neurochem 2005; 95: 834-47.
17. Englund H, Sehlin D, Johansson AS et al. Sensitive ELISA detection of amyloid-β protofibrils in biological samples. J Neurochem 2007; 103: 334-45.
18. Lindhagen-Persson M, Brännström K, Vestling M et al. Amyloid-β oligomer specificity mediated by the IgM isotype-implications for a specific protective mechanism exerted by endogenous auto-antibodies. PLoS One 2010; 5: e13928.
19. Bruggink KA, Jongbloed W, Biemans EALM et al. Amyloid-β oligomer detection by ELISA in cerebrospinal fluid and brain tissue. Anal Biochem 2013; 433: 112-20.
20. Howlett D, Perry A, Godfrey F et al. Inhibition of fibril formation in β-amyloid peptide by a novel series of benzofurans. Biochem J 1999; 340: 283-9.
21. Sian A, Frears E, El-Agnaf O et al. Oligomerization of β-amyloid of the Alzheimer's and the Dutch-cerebral-haemorrhage types. Biochem J 2000; 349: 299-308.
22. Schupf N, Tang MX, Fukuyama H et al. Peripheral A β subspecies as risk biomarkers of Alzheimer's disease. Proc Natl Acad Sci USA 2008; 105: 14052-57.
23. Yoshiike Y, Minai R, Matsuo Y et al. Amyloid oligomer conformation in a group of natively folded proteins. PLoS One 2008; 3: e3235.
24. Groenning M. Binding mode of thioflavin T and other molecular probes in the context of amyloid fibrils-current status. J Chem Biol 2010; 3: 1-18.
25. Biancalana M, Koide S. Molecular mechanism of Thioflavin-T binding to amyloid fibrils. Biochim Biophys Acta 2010; 1804: 1405-12.
26. Chen M, Inestrosa NC, Ross GS, Fernandez HL. Platelets are the primary source of amyloid beta-peptide in human blood. Biochem Biophys Res Commun 1995; 213: 96-103.
27. Koudinov AR, Berezov TT, Kumar A et al. Alzheimer's amyloid β interaction with normal human plasma high density lipoprotein: association with apolipoprotein and lipids. Clin Chim Acta 1998; 270: 75-84.
28. Kuo YM, Kokjohn TA, Kalback W et al. Amyloid-β peptides interact with plasma proteins and erythrocytes: implications for their quantitation in plasma. Biochem Biophys Res Commun 2000; 268: 750-6.
29. Järemo P, Milovanovic M, Nilsson S et al. Alzheimer's disease is characterized by more low-density erythrocytes with increased volume and enhanced β-amyloid x-40 content. J Intern Med 2011; 270: 489-92.
30. Singer SJ, Dewji NN. Evidence that Perutz's double-betastranded subunit structure for beta-amyloids also applies to their channel-forming structures in membranes. Proc Natl Acad Sci USA 2006; 103: 1546-50.